Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

TELA Bio (TELA) Total Liabilities (2018 - 2025)

TELA Bio has reported Total Liabilities over the past 8 years, most recently at $75.1 million for Q4 2025.

  • Quarterly results put Total Liabilities at $75.1 million for Q4 2025, up 29.24% from a year ago — trailing twelve months through Dec 2025 was $75.1 million (up 29.24% YoY), and the annual figure for FY2025 was $75.1 million, up 29.24%.
  • Total Liabilities for Q4 2025 was $75.1 million at TELA Bio, up from $60.0 million in the prior quarter.
  • Over the last five years, Total Liabilities for TELA hit a ceiling of $75.1 million in Q4 2025 and a floor of $36.6 million in Q1 2021.
  • Median Total Liabilities over the past 5 years was $56.5 million (2022), compared with a mean of $53.9 million.
  • Biggest five-year swings in Total Liabilities: skyrocketed 36.96% in 2022 and later decreased 1.78% in 2024.
  • TELA Bio's Total Liabilities stood at $42.4 million in 2021, then rose by 26.16% to $53.6 million in 2022, then grew by 10.49% to $59.2 million in 2023, then dropped by 1.78% to $58.1 million in 2024, then grew by 29.24% to $75.1 million in 2025.
  • The last three reported values for Total Liabilities were $75.1 million (Q4 2025), $60.0 million (Q3 2025), and $58.4 million (Q2 2025) per Business Quant data.